首页> 外文期刊>Thyroid Research >Semi-quantitative assessment of diffuse hepatic uptake seen in I-131 scans – an indicator of functioning thyroid tissue and disease burden in differentiated thyroid cancer
【24h】

Semi-quantitative assessment of diffuse hepatic uptake seen in I-131 scans – an indicator of functioning thyroid tissue and disease burden in differentiated thyroid cancer

机译:在I-131扫描中观察到的弥漫性肝摄取的半定量评估-分化的甲状腺癌中甲状腺组织功能正常和疾病负担的指标

获取原文
       

摘要

To semi-quantitatively analyze liver uptake of I-131 in diagnostic and post-therapy scans by calculating hepatic to thigh ratios (HTR) and evaluate its clinical significance in management of differentiated thyroid cancer. Two hundred forty-nine patients were included in the study. Hepatic to thigh ratio (HTR) of counts were calculated for 249 diagnostic and 104 post-therapy scans. Patients were divided into six study groups based on their disease status:1-Serum thyroglobulin (serum Tg) negative (serum Tg?≤?4?ng/dl) and scan negative; 2-Thyroid remnant only; 3-Thyroid remnant and lymph node metastasis; 4- Tg positive (serum Tg??4?ng/dl) and scan negative; 5-Bone or/and lung metastasis, and 6-Only lymph node metastasis. Comparison of HTR between these groups was done using one-way ANOVA test. Correlation of HTR with serum Tg, serum thyroid stimulating hormone (TSH), anti-thyroglobulin antibody (ATg) titer and therapeutic dose of I-131 was also assessed. Comparison of HTR between different study groups (1 to 6) showed significant difference in HTR (p?=?.001). Study group 5 (bone or/and lung metastasis) showed significantly higher mean HTR compared to other groups (p?=?0.001). There was only a weak correlation between serum Tg and HTR (r?=?0.395). Dose of I-131 administered also had a weak correlation with HTR (r?=?0.207). HTR has good correlation with functional status of tumor cells, while it has weak correlation to therapeutic dose of I-131 administered and serum Tg. Increased HTR predicts significant disease burden in the form of distant bone and lung metastasis and may potentially be used as a second prognostic factor apart from serum Tg.
机译:通过计算肝大腿比(HTR)来半定量分析I-131在诊断和治疗后扫描中的肝脏摄取情况,并评估其在分化型甲状腺癌管理中的临床意义。该研究包括249名患者。计算了249次诊断性扫描和104次治疗后扫描的肝大腿比率(HTR)。根据疾病状况将患者分为六个研究组:1-血清甲状腺球蛋白(血清Tg)阴性(血清Tg≥4?ng / dl),扫描阴性。仅2-甲状腺残基; 3-甲状腺残余和淋巴结转移; 4-Tg阳性(血清Tg≥4≤ng/ dl),扫描阴性。 5-骨或/和肺转移,以及仅6-淋巴结转移。使用单向方差分析对这些组的HTR进行比较。还评估了HTR与血清Tg,血清甲状腺刺激激素(TSH),抗甲状腺球蛋白抗体(ATg)滴度和I-131治疗剂量的相关性。不同研究组(1至6个)之间的HTR比较显示HTR有显着差异(p?= ?. 001)。第5研究组(骨或/和肺转移)的平均HTR显着高于其他组(p≤0.001)。血清Tg与HTR之间的相关性很弱(r = 0.395)。服用I-131的剂量与HTR的关系也很弱(r?=?0.207)。 HTR与肿瘤细胞的功能状态具有良好的相关性,而与I-131的治疗剂量和血清Tg的相关性较弱。 HTR升高预示着远处骨和肺转移的严重疾病负担,除血清Tg之外,还可能被用作第二个预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号